D. Culkin

发表

Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progressioan

J. Wren, K. Fung, Hsueh-Kung Lin, 2010, BMC Cancer.

Radical prostatectomy versus observation for localized prostate cancer.

Timothy J Wilt, Michael J Barry, Steven Fox, 2012, The New England journal of medicine.

Unique patterns of molecular profiling between human prostate cancer LNCaP and PC‐3 cells

Hsueh-Kung Lin, M. Dozmorov, R. Hurst, 2009, The Prostate.

Bladder dysfunction and neurosyphilis.

D. Culkin, J. Wheeler, R. O’Hara, 1986, The Journal of urology.

Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation.

C. Comiter, D. Culkin, E. Bird, 2016, Urology.

Clinical strategies in the management of biochemical recurrence after radical prostatectomy.

D. Culkin, R. A. Zimmerman, 2003, Clinical prostate cancer.

Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.

R. Hurst, D. Culkin, G. Slobodov, 2004, The Journal of urology.

Comparison of a new length measurement technique for inflatable penile prosthesis implantation to standard techniques: outcomes and patient satisfaction.

D. Culkin, D. Ohl, R. Shabsigh, 2011, The journal of sexual medicine.

Percutaneous nephrolithotomy: spinal cord injury vs. ambulatory patients.

D. Culkin, B. Nemchausky, J. Wheeler, 1990, The Journal of the American Paraplegia Society.

Treatment of renal calculus in inferior crossed renal ectopia.

D. Culkin, J. Wheeler, J. Canning, 1988, Urology.

Distal ureteral obstruction complicating percutaneous nephrolithotomy.

D. Culkin, J. Wheeler, J. Canning, 1987, Urology.

Percutaneous nephrolithotomy in the spinal cord injury population.

D. Culkin, B. Nemchausky, J. Wheeler, 1986, The Journal of urology.

Surgical Management of Urolithiasis in Spinal Cord Injury Patients

D. Culkin, G. Slobodov, Philippe Nabbout, 2014, Current Urology Reports.

Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper.

A. Gross, M. Desai, M. Soloway, 2014, The Journal of urology.

Early Evaluation of Hematuria in a Patient Receiving Anticoagulant Therapy and Detection of Malignancy

D. Culkin, S. Blevins, Toni L. Ripley, 2004, Pharmacotherapy.

American Urological Association ( AUA ) Guideline EVALUATION AND TREATMENT OF CRYPTORCHIDISM : AUA GUIDELINE

R. Breau, S. Docimo, T. Averch, 2014 .

From microarray to biology: an integrated experimental, statistical and in silico analysis of how the extracellular matrix modulates the phenotype of cancer cells

Mikhail G. Dozmorov, Kimberly D. Kyker, Paul J. Hauser, 2008, BMC Bioinformatics.

A model for 3-dimensional growth of bladder cancers to investigate cell-matrix interactions.

R. Hurst, D. Culkin, K. Kyker, 2003, Urologic oncology.

Positive bethanechol supersensitivity test in neurologically normal patients.

D. Culkin, J. Wheeler, J. Canning, 1988, Urology.

Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients.

Xue-Ru Wu, P. Hauser, C. Davis, 2008, American journal of physiology. Renal physiology.

5α-androstane-3α,17β-diol selectively activates the canonical PI3K/AKT pathway: a bioinformatics-based evidence for androgen-activated cytoplasmic signaling

Qing Yang, Hsueh-Kung Lin, M. Dozmorov, 2007, Genomic Medicine.

Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder

C. Comiter, D. Culkin, E. Bird, 2016, Neurourology and urodynamics.

Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6‐months in subjects with mild symptoms of overactive bladder

C. Comiter, D. Culkin, E. Bird, 2015, Neurourology and urodynamics.

Influence of hepatic function on serum levels of prostate specific antigen.

J. Eastham, O. Sartor, D. Culkin, 1997, The Journal of urology.

Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true?

M. Araki, D. Culkin, Po N. Lam, 2007, Urology.

Prostate specific antigen is metabolized in the liver.

D. Culkin, J. Roy, E. Schechter, 1996, The Journal of urology.

Advanced penile carcinoma.

T. Beer, D. Culkin, 2003, The Journal of urology.

Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study.

G. Haas, C. Russell, E. Crawford, 1999, The Journal of urology.

Physician and patient satisfaction with the new AMS 700 momentary squeeze inflatable penile prosthesis.

D. Culkin, D. Ohl, R. Shabsigh, 2009, The journal of sexual medicine.

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.

Daniel J. Culkin, Patrick J. Loehrer, I. Thompson, 1998, New England Journal of Medicine.

Primary mixed neuroendocrine carcinoma of the bladder with large cell component: a case report and review of the literature

S. Lightfoot, D. Culkin, G. Slobodov, 2012, International Urology and Nephrology.

Does Greenlight HPS(™) laser photoselective vaporization prostatectomy affect sexual function?

M. Araki, M. Spaliviero, D. Culkin, 2010, Journal of endourology.

Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis.

P. Hauser, R. Hurst, D. Culkin, 2012, Urology.

Restoration of the Barrier Function to Acid-Damaged Bladder by Intravesical Chondroitin Sulfate

P. Hauser, R. Hurst, D. Culkin, 2011 .

Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

P. Hauser, R. Hurst, D. Culkin, 2009, The Journal of urology.

Fourniers gangrene in children

John R. Adams, D. Culkin, J. Bocchini, 1990 .

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.

I. Thompson, G. Miller, G. Wilding, 1998, The New England journal of medicine.

Injury to the male external genitalia: a comprehensive review

D. Culkin, J. Furr, 2017, International Urology and Nephrology.

A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.

E. Messing, G. Sant, R. Mayer, 2003, The Journal of urology.

Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients.

M. Araki, M. Spaliviero, D. Culkin, 2009, Journal of endourology.

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.

K. Burgio, J. Clemens, D. Culkin, 2012, The Journal of urology.

Unresectable calcified bladder tumor: hemiacidrin irrigation as an adjunct to resection.

D. Culkin, D. Venable, W. Bundrick, 1991, Journal of Urology.

Preoperative JJ stent placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study

A. Crisci, M. Duvdevani, D. Assimos, 2015, BJU international.

Extracorporeal Shock Wave Lithotripsy in Patients With Spinal Cord Dysfunction

John R. Adams, D. Culkin, J. Wheeler, 1990 .

Anatomic, functional, and pathologic changes from internal ureteral stent placement.

D. Culkin, S. Ledbetter, V. Price, 1992, Urology.

Nephro-duodenal fistula: a complication of percutaneous nephrolithotomy.

D. Culkin, J. Wheeler, J. Canning, 1985, The Journal of urology.

Current management of urolithiasis in the spinal cord injury patient.

D. Culkin, J. Wheeler, 1987, The Journal of the American Paraplegia Society.

Spontaneous intraperitoneal vesical rupture in association with neuropathic bladder

D. Culkin, J. Wheeler, D. Venable, 1990, Paraplegia.

Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumor.

K. Fung, Hsueh-Kung Lin, T. Penning, 2010, International journal of clinical and experimental pathology.

Acquired immunodeficiency syndrome manifesting as prostate nodule secondary to cryptococcal infection.

D. Culkin, M. Fowler, D. Venable, 1992, Urology.

Fournier's gangrene in children.

D. Culkin, J. Bocchini, D. Venable, 1990, Urology.

Nocardia epididymo-orchitis in an immunosuppressed patient.

D. Culkin, J. Wheeler, J. O'Connell, 1986, The Journal of urology.

Epidemiology and Natural History

M. Spaliviero, D. Culkin, 2014 .

Review Article ADVANCED PENILE CARCINOMA

T. Beer, D. Culkin, 2003 .

Cancer of the Penis

K. Stratton, D. Culkin, Jonathan E. Heinlen, 2020, Abeloff's Clinical Oncology.

Testicular nodule incidentally found in elderly male.

G. Chejfec, D. Culkin, V. Gould, 1986, Ultrastructural pathology.

Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.

J. Pitha, K. Fung, Hsueh-Kung Lin, 2006, Endocrine-related cancer.

Erectile Dysfunction: AUA Guideline

M. Faraday, R. Breau, K. McVary, 2018, The Journal of urology.

Carcinoma of the prostate in a 25-year-old man: a case report and review of the literature.

D. Culkin, J. Wheeler, M. Castelli, 1986, The Journal of urology.

Acute urinary retention in a child with appendiceal abscess: diagnostic dilemma.

D. Culkin, D. Venable, S. Willis, 1990, Urology.

Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis.

P. Hauser, M. Dozmorov, R. Hurst, 2008, The Journal of urology.

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial

E. Messing, I. Thompson, C. Tangen, 2018, JAMA.

A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis.

E. Messing, G. Sant, J. Kusek, 2005, The Journal of urology.

Female urinary retention.

R. Flanigan, D. Culkin, J. Walter, 1990, Urology.

Urethrorectal fistula: transanal, transsphincteric approach with locally based pedicle interposition flaps.

D. Culkin, Christopher E Ramsey, 2003, The Journal of urology.

Percutaneous nephrolithotomy in spinal cord neuropathy patients: a single institution experience.

D. Culkin, G. Slobodov, A. Mellis, 2012, Journal of endourology.

Peyronie's Disease: AUA Guideline.

M. Faraday, K. McVary, C. Nelson, 2015, The Journal of urology.

Incidental ileal carcinoid associated with multiple urologic malignancies.

D. Culkin, D. Venable, J. Mata, 1991, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

Cellular PSA in benign and malignant prostate

D. Culkin, F. Gelder, D. Venable, 1995, The Prostate.

Evaluation of a new tumor marker for localized prostate cancer

D. Culkin, F. Gelder, D. Venable, 1992, The Prostate.

A Contemporary Review of HPV and Penile Cancer.

K. Stratton, D. Culkin, 2016, Oncology.

Wilms' tumor with renal cell carcinoma overgrowth in a 3-year-old child.

D. Culkin, B. Kropp, S. F. Johnson, 1998, Urology.

A seventy-six-year-old man with mild azotemia.

D. Culkin, D. Venable, W. Bundrick, 1992, Urology.

Idiopathic anejaculation treated by vibratory stimulation.

D. Culkin, J. Walter, J. Wheeler, 1988, Fertility and sterility.

Recurrent malignant melanoma of the penis.

D. Culkin, Stephen D. Confer, Charles C. Te, 2008, Urology.

Case Report Recurrent Malignant Melanoma of the Penis

D. Culkin, Stephen D. Confer, Charles C. Te, 2008 .

Ultrasound guided percutaneous renal biopsy using an automatic core biopsy system.

D. Culkin, D. Venable, J. Mata, 1991, The Journal of urology.

American Urological Association ( AUA ) Guideline PEYRONIE ’ S DISEASE : AUA GUIDELINE

M. Faraday, K. McVary, C. Nelson, 2017 .

Follow‐up of Prostatectomy versus Observation for Early Prostate Cancer

T. Wilt, M. Barry, G. Andriole, 2017, The New England journal of medicine.

Percutaneous nephrostomy for palliation of metastatic ureteral obstruction.

D. Culkin, J. Wheeler, J. Canning, 1987, Urology.

Five‐Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation

C. Comiter, D. Culkin, E. Bird, 2018, The Journal of urology.

Cystic carcinoma of the prostate.

D. Culkin, B. Bane, A. Agha, 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Bladder cancer in spinal cord injury patients.

D. Culkin, A. Bickel, J. Wheeler, 1991, The Journal of urology.

Ureteral catheter tip separation: potential risk using the open-end Flexi-Tip ureteral catheter.

D. Culkin, A. Bickel, D. Venable, 1991, The Journal of urology.

Techniques for bypassing and stenting ureteral obstructions.

D. Culkin, D. Venable, J. Mata, 1994, The Journal of urology.

1185: Sacral Neuromodulation: Long Term Experience

D. Culkin, G. Slobodov, B. Palmer, 2007 .

APS recommendations for the urological evaluation of patients with spinal cord injury.

D. Culkin, T. Linsenmeyer, 1999, The journal of spinal cord medicine.

Screening and identification of differentially expressed transcripts in circulating cells of prostate cancer patients using suppression subtractive hybridization

Hsueh-Kung Lin, A. Metwalli, D. Culkin, 2005, Molecular Cancer.

Hydronephrosis in a woman undergoing in vitro fertilization.

K. Hansen, D. Culkin, Stephen D. Confer, 2007, Urology.

Penile malignant melanoma in association with squamous cell carcinoma of the penis.

D. Culkin, D. Venable, W. Bundrick, 1991, The Journal of urology.

Recent trends in surgical treatment of localized prostate cancer.

B. Link, D. Culkin, 2005, Clinical prostate cancer.

Perineal urethrocutaneous fistula complicating ischiectomy.

D. Culkin, R. Chintam, B. Nemchausky, 1988, The Journal of urology.

Ascertaining cause of death among men in the Prostate Cancer Intervention Versus Observation Trial

T. Wilt, M. Barry, G. Andriole, 2013, Clinical trials.

Analysis of immunological alterations associated with testicular prostheses.

J. Henderson, D. Culkin, D. Venable, 1995, The Journal of urology.

Programmed death ligand 1 expression and human papillomavirus status: penile cancer prognostic factors and new therapeutic opportunities

K. Stratton, D. Culkin, M. Ramadan, 2016 .

Naloxone efficacy in bladder rehabilitation of spinal cord injury patients.

C. Robinson, D. Culkin, B. Nemchausky, 1987, The Journal of urology.

Leiomyoma of the female urethra.

D. Culkin, J. Wheeler, E. St. Martin, 1988, The Journal of urology.

System level changes in gene expression in maturing bladder mucosa.

A. Sabichi, J. Clifford, P. Hauser, 2011, The Journal of urology.

5α-Androstane-3α,17β-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation

I. Dozmorov, Y. Tang, M. Centola, 2004, Prostate Cancer and Prostatic Diseases.

Advanced penile cancer

D. Culkin, D. Buethe, Jonathan E. Heinlen, 2012, International Urology and Nephrology.

Ureteral stump carcinoma incidentally found at cystectomy for bladder cancer.

R. Flanigan, D. Culkin, J. Wheeler, 1991, Urology.

Maxi-pouch: a new technique for ileal conduit conversion to continent urinary reservoir.

D. Culkin, J. Mata, R. Humble, 1990, Journal of Urology.

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.

K. Burgio, J. Clemens, D. Culkin, 2012, The Journal of urology.

Xanthogranulomatous Cystitis Presenting as Urinary Incontinence and a Vesicovaginal Fistula: a Case Report and Review of the Literature

D. Culkin, A. Mellis, Shivon Abdullah, 2011 .

Evaluation and treatment of cryptorchidism: AUA guideline.

Andrew C. Peterson, P. Dahm, R. Breau, 2014, The Journal of urology.

Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.

M. Kattan, J. Eastham, O. Sartor, 1997, Journal of the National Cancer Institute.

Muscle–invasive bladder cancer in a young adult: a case report and a review of the literature

D. Culkin, G. Slobodov, A. Eldefrawy*, 2013, Central European journal of urology.

Evaluation of the current incidence of nodal metastasis from prostate cancer

D. Culkin, D. Venable, W. Bundrick, 1993, Journal of surgical oncology.

Multiple Endocrine Neoplasia 2a Presenting with Pheochromocytoma and Pituitary Macroadenoma

D. Culkin, G. Slobodov, D. Buethe, 2011, ISRN oncology.

Preoperative JJ stent placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study

A. Crisci, M. Duvdevani, D. Assimos, 2015, BJU international.

Evaluation and treatment of cryptorchidism: AUA Guideline

R. Breau, H. Salem, S. Docimo, 2019 .

Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.

R. Hurst, D. Culkin, G. Slobodov, 2004, The Journal of urology.

INTRAVESICALLY APPLIED CHONDROITIN SULFATE RESTORES UROTHELIAL BARRIER FUNCTION IN ACID-DAMAGED BLADDER

P. Hauser, R. Hurst, D. Culkin, 2009 .

Cancer of the Penis

K. Stratton, D. Culkin, Jonathan E. Heinlen, 2020, Abeloff's Clinical Oncology.